MED19 (mediator complex subunit 19)

2003-06-01  

Identity

HGNC
LOCATION
11q12.1
LOCUSID
ALIAS
DT2P1G7,LCMR1,MED19AS
FUSION GENES

Other Information

Locus ID:

NCBI: 219541
MIM: 612385
HGNC: 29600
Ensembl: ENSG00000156603

Variants:

dbSNP: 219541
ClinVar: 219541
TCGA: ENSG00000156603
COSMIC: MED19

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000156603ENST00000337672A0JLT2
ENSG00000156603ENST00000431606J3KR33
ENSG00000156603ENST00000645681A0JLT2

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45

Pathways

PathwaySourceExternal ID
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)REACTOMER-HSA-400206
PPARA activates gene expressionREACTOMER-HSA-1989781
Developmental BiologyREACTOMER-HSA-1266738
Transcriptional regulation of white adipocyte differentiationREACTOMER-HSA-381340

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA443309AlcoholismDiseaseClinicalAnnotationassociatedPD32451486
PA448073ethanolChemicalClinicalAnnotationassociatedPD32451486

References

Pubmed IDYearTitleCitations
378802762023MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs.0
378802762023MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs.0
351846512022Lung cancer metastasis-related protein 1 promotes the transferring from advanced metastatic prostate cancer to castration-resistant prostate cancer by activating the glucocorticoid receptor α signal pathway.4
351846512022Lung cancer metastasis-related protein 1 promotes the transferring from advanced metastatic prostate cancer to castration-resistant prostate cancer by activating the glucocorticoid receptor α signal pathway.4
335131332021MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.7
340381902021The role of mediator complex subunit 19 in human diseases.2
335131332021MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.7
340381902021The role of mediator complex subunit 19 in human diseases.2
301612872019Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer.14
305830762019Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.20
317156652019[Knockdown of mediator complex subunit 19 suppresses the migration and invasion and epithelial-mesenchymal transition in prostate cancer PC3 cells].0
301612872019Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer.14
305830762019Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.20
317156652019[Knockdown of mediator complex subunit 19 suppresses the migration and invasion and epithelial-mesenchymal transition in prostate cancer PC3 cells].0
273750182017A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.11

Citation

Dessen P

MED19 (mediator complex subunit 19)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/41131/teaching-explorer/css/card-gene.css